Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 4Neoplasms 2Acromegaly 2Serotonin Syndrome 1Pituitary Neoplasms 1Pancreatitis 1Pancreatic Intraductal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Fistula 1Duodenal Neoplasms 1Diarrhea 1Colorectal Neoplasms 1Carcinoid Tumor 1Breast Neoplasms 1Brain Neoplasms 1Adenoma 1

Interventions

lanreotide 2Octreotide 2Cabergoline 2pegvisomant 1pasireotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Acromegaly × Octreotide × Clear all
NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Novartis

Phase 4 Completed
20 enrolled
CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT00171886 2017-02-24

Octreotide Efficacy and Safety in First-line Acromegalic Patients

Novartis

Phase 4 Completed
20 enrolled

Acromegaly

Data powered by HemOnc (CC BY 4.0) Colophon âš¡